Bernstein Remains a Sell on Genmab (GMAB) - The Globe and Mail

Retrieved on: 2025-09-14 05:45:00

Tags for this article:

Click the tags to see associated articles and topics

Bernstein Remains a Sell on Genmab (GMAB) - The Globe and Mail. View article details on hiswai:

Excerpt

Smith covers the Healthcare sector, focusing on stocks such as Pfizer, AstraZeneca, and Roche Holding AG. Currently, the analyst consensus on ...

Article found on: www.theglobeandmail.com